Therefore, our hypothesis was that overexpression of miR‐34a‐5p may inhibit the expression of SIRT1 and up‐regulation of IL‐1β/COX2/PEG2, thereby triggering the release of CGRP to induce the pain during migraine. The gene discussed is PTGS2; the disease is migraine disorder.